Position in ALKS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$4,796,937
+$1,009,033 QoQ
Shares Held
135,660
+0.2% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ALPS ADVISORS INC holds $13,007,217 across 10 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
135,660 | $4,796,937 | |
| 2 | ZTS |
Zoetis Inc.
|
26,087 | $3,083,744 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
89,983 | $1,250,763 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
63,836 | $884,128 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
60,250 | $573,580 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
10,010 | $553,653 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
921 | $546,134 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
7,030 | $540,607 |
All Filings in ALKS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,796,937 | 135,660 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $3,787,904 | 135,379 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,334,960 | 77,832 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $2,543,686 | 88,909 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $3,821,470 | 115,732 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $3,762,900 | 130,838 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,532,953 | 126,222 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,181,007 | 131,992 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,190,091 | 117,846 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,242,861 | 116,902 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,442,877 | 122,916 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,830,713 | 122,387 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,053,230 | 108,309 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $2,909,392 | 111,343 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,003,045 | 89,702 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,907,265 | 97,592 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,390,060 | 166,859 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,363,250 | 187,586 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $6,112,673 | 198,206 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,159,915 | 210,437 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $5,378,681 | 287,938 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $5,735,086 | 287,473 | Shares | Defined | 2021-02-03 | |
| 2020-06-30 | $4,202,963 | 216,536 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $4,117,631 | 285,550 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||